Humacyte HUMA
NASDAQ HUMA
$0.52 0.00 (-0.33%)
As of: Oct 1, 2026 · 2:36 PM EDT

Humacyte (HUMA) Gross Margin (2025 - 2026)

Updated

Humacyte's Gross Margin came in at -203.20% for Q2 2026, down 232.44 percentage points from 29.24% a year earlier but up 108.52 percentage points from the prior quarter.

Analysis

Humacyte (HUMA) Gross Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Humacyte reported Gross Margin of -494.58%, down 550.57 percentage points year-over-year; for FY2025, it was -376.05%.

  • The five-year range for quarterly Gross Margin is -1844.75% (Q4 2025) to 71.57% (Q1 2025).
  • Business Quant data shows HUMA's Gross Margin at -311.72% (Q1 2026), -1844.75% (Q4 2025) and 65.47% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00 -203.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -203.20%
Mar 31, 2026 -311.72%
Dec 31, 2025 -1,844.75%
Sep 30, 2025 65.47%
Jun 30, 2025 29.24%
Mar 31, 2025 71.57%
API Access

Humacyte Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=HUMA&period=max&api_key=YOUR_API_KEY